Skip to main content

Table 5 Duration of dysesthesia and paresthesias (21 day cycles)

From: Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer

Dysesthesias
Cycle number Median duration (days) Percent persisting ≥ 14 days Percent persisting ≥ 21 days
1 5 9.5% 3.2%
3 7 14.3% 6.1%
6 10.5 38.2% 17.6%
9 13.5 50% 37.5%
12 21 60% 60%
Paresthesias
Cycle number Median duration (days) Percent persisting ≥ 14 days Percent persisting ≥ 21 days
1 7 19.7% 6.1%
3 12.5 35.6% 18.6%
6 14 54.3% 37%
9 = 21 86.4% 77.3%
12 = 21 83.3% 83.3%
\